July 31, 2017 / 10:39 AM / 7 months ago

BRIEF-BioLife Solutions executes supply agreement with Celyad for CryoStor

July 31 (Reuters) - BioLife Solutions Inc

* Biolife Solutions executes supply agreement with Celyad for CryoStor use in natural killer receptor based t-cell (nkr-t) platform targeting solid tumors and blood cancers

* Biolife Solutions Inc - has executed a long term supply agreement with Celyad

* Biolife Solutions Inc - co’s CryoStor clinical grade cell freeze media is incorporated into Celyad’s manufacturing process Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below